TAO Synergies (TAOX) EPS (Basic) (2019 - 2026)
TAO Synergies' (TAOX) quarterly EPS (Basic) came in at -$1.83 in Q2 2026, up 83.76% on a YoY basis from -$0.99 in Q2 2025, and down 510.03% quarter-over-quarter from $0.45 in Q1 2026.
Powered by 
Analysis
TAO Synergies (TAOX) EPS (Basic) (2019 - 2026) Analysis & Trends
TAO Synergies (TAOX) has reported EPS (Basic) for 8 consecutive years, with -$1.83 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 83.76% year-over-year to -$1.83; the trailing twelve-month figure through Jun 2026 stood at -$2.95 (up 84.15% YoY), and the FY2025 full-year result was -$8.81, up 19.83% from the prior year.
- EPS (Basic) fell to -$1.83 in Q2 2026 per TAOX's latest filing, from $0.45 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.62 in Q4 2022 and bottomed at -$11.26 in Q2 2025.
- Historically, EPS (Basic) has averaged -$1.66 across 5 years, with a median of -$0.51 in 2022.
- The sharpest annual moves came in 2024 and 2026: EPS (Basic) slumped 13469.82% in 2024, then surged 268.05% in 2026.
- Over 5 years, EPS (Basic) stood at $0.62 in 2022, then sank by 116.89% to -$0.11 in 2023, then sank by 4244.53% to -$4.58 in 2024, then soared by 48.63% to -$2.36 in 2025, then gained by 22.39% to -$1.83 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.83, $0.45, and -$2.36 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | -0.40 |
| 10 | TAO Synergies | 30.41 Mn | 30.41 Mn | - | -1.83 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.83 |
| Mar 31, 2026 | 0.45 |
| Dec 31, 2025 | -2.36 |
| Sep 30, 2025 | -1.56 |
| Jun 30, 2025 | -11.26 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | -4.58 |
| Sep 30, 2024 | -4.58 |
| Jun 30, 2024 | -1.18 |
| Mar 31, 2024 | -0.41 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | -0.03 |
| Jun 30, 2023 | -1.39 |
| Mar 31, 2023 | -0.26 |
| Dec 31, 2022 | 0.62 |
| Sep 30, 2022 | -0.43 |
| Jun 30, 2022 | -0.54 |
| Mar 31, 2022 | -0.47 |
| Dec 31, 2021 | -0.84 |
| Sep 30, 2021 | -0.47 |